EyePoint Pharmaceuticals Competitors and Similar CompaniesClear all
EyePoint Pharmaceuticals's competitors and similar companies include Sol-Gel Technologies and dMed.
 EyePoint Pharmaceuticals EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. |  Sol-Gel Technologies Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals. |  dMed dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities. | |
Founding Date | Founding Date 1987 | Founding Date 1997 | Founding Date 2016 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Watertown, US HQ | Locations Ness Ziona, IL HQ | Locations Morrisville, US HQ |
Employees | Employees 8453% increase | Employees 34 | Employees 172 |
Valuation ($) | Valuation ($) 617.6 m | Valuation ($) 18 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $31.4m (FY, 2025) | Revenue (est.) $19.4m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($232m) (FY, 2025) | Net income ($6.1m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 40m | Total funding raised N/A | Total funding raised $ 208m |
For sources of this data, please see the company profile
View Company Profiles
Sol-Gel Technologies
HQ
Ness Ziona, IL
Employees
34
Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals.
View companydMed
HQ
Morrisville, US
Employees
172
dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities.
View company